Streetbeat News

Earnings

INKT

MiNK Therapeutics (NASDAQ:INKT) reported a Q4 EPS loss of $(0.16), missing the consensus estimate of $(0.15) by 6.67%. However, this represents a 30.43% improvement over the $(0.23) per share loss from the same period last year.

Portfolio Pulse from dijoy@benzinga.com

March 21, 2024 | 11:06 am

MDWD

MediWound (NASDAQ:MDWD) reported Q4 earnings with losses of $(0.19) per share, surpassing the $(0.23) estimate, and sales of $5.34M, slightly above the $5.32M estimate. This represents an 83.9% improvement in losses and a 54.05% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:05 am

DRI

Darden Restaurants projects its adjusted earnings per share (EPS) from continuing operations for 2024 to be between $8.80 and $8.90, with total sales expected to be around $11.4 billion, slightly below the estimated $11.51 billion.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:05 am

KIRK

Kirkland's reported Q4 sales of $165.95M, missing the consensus estimate of $167.22M by 0.76% but marking a 2.14% increase from the previous year's $162.48M.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:04 am

DRI

Darden Restaurants (NYSE:DRI) reported Q3 2024 earnings of $2.62 per share, meeting analyst estimates, but missed revenue expectations with $2.975 billion against a forecast of $3.025 billion, a 1.65% miss. This represents a 6.78% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:03 am

MLYS

Mineralys Therapeutics (NASDAQ:MLYS) reported a Q4 EPS loss of $(0.61), surpassing the analyst consensus estimate of $(0.82) by 25.61%. This marks a 64.94% improvement over the $(1.74) per share loss from the same period last year.

Portfolio Pulse from dijoy@benzinga.com

March 21, 2024 | 11:03 am

WGO

Winnebago Industries reported Q2 adjusted EPS of $0.93, surpassing the $0.85 estimate, but its sales of $703.60M fell short of the $706.45M estimate. This represents a significant decrease in both earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:03 am

DXLG

Destination XL Group (DXLG) reported Q4 adjusted EPS of $0.10, surpassing the $0.06 estimate, but sales of $137.14M fell short of the $138.29M estimate. This represents a 23.08% decrease in earnings and a 4.68% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:03 am

APYX

Apyx Medical (NASDAQ:APYX) reported Q4 GAAP EPS of $(0.28), missing the $(0.18) estimate by 55.56%, and a 64.71% decrease from last year's $(0.17) per share. Sales were $14.66M, missing the $14.85M estimate by 1.27%, but represent a 16.26% increase from last year's $12.61M.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:01 am

GAMB

Gambling.com Gr (NASDAQ:GAMB) reported Q4 2023 adjusted EPS of $0.18, missing the $0.19 estimate, but sales of $32.530M exceeded the $27.688M estimate, marking a 52.37% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:01 am